People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
At 2cureX, we’re pioneers of 3D microtumors in cancer therapy, focused on improving the outcomes of cancer treatment
2cureX launches IndiTreat® for metastasised colon cancer, the world’s first CE validated IVD based on microtumors
Fight Cancer 2021, Redeye Event, Stockholm
Click here for more information
VATOR SWISS NORDIC BIO 2021 – The Annual Nordic Healthcare Investor Summit in Zürich
2cureX Year-End Report 2020
View previous reports
IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.